Sorrento Therapeutics (NASDAQ:SRNE) Earns Hold Rating from Analysts at StockNews.com
StockNews.com initiated coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Free Report) in a report published on Friday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Sorrento Therapeutics Trading Down 12.8 % Shares of NASDAQ SRNE opened at $0.01 on Friday. Sorrento Therapeutics has a 12 month low of $0.00 and […]
More Stories
Going Off Blood Pressure Meds Linked to Better Cognition
By Huey Freeman Taking older adults off their blood pressure medication was linked to slower cognitive decline, especially in those...
US Consumer Confidence Nosedives Amid Growing Concerns Over Job Security
By Tom Ozimek U.S. consumer confidence took a sharp dive in September, driven by rising concerns over job security and...
Florida Counties Issue Mandatory Evacuations Ahead of Tropical Storm Helene
By T. J. Muscaro Floridians in several counties were ordered to evacuate on Sept. 24, as the state prepares for...
Senator Warns of Looming Port Strike That Threatens to Cripple US Supply Chain
By Jack Phillips A U.S. senator on Tuesday warned of economic repercussions ahead of a threatened strike at major East...
The Fed’s 0.5% Rate Cut Delivered New Market Highs
By Louis Navellier Last Wednesday, the Federal Open Market Committee (FOMC) statement announced a surprising 0.5% key interest rate cut...
Pennsylvania County Must Update Voters on Mail-In Ballot Status
By Zachary Stieber A Pennsylvania county must inform voters if their mail-in ballots have been counted or rejected, a state...